BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Drug Development

  Arch Biopartners Announces Completion of GMP Manufacturing of AB569 and Start Date of Phase I Trial

  AB569 is the Company’s inhalation drug candidate for treating antibiotic-resistant bacterial infections in the lungs of cystic fibrosis.

  December 6, 2017

   · 

  3 min read
• Business

  Clinigen Plc Directorate Change

  Clinigen announces that Chris Rigg has resigned with immediate effect as a director to seek a CEO role elsewhere.

  December 6, 2017

   · 

  1 min read
• Business

  Domainex Appoints Chris Brown as CFO

  Chris will have a pivotal role in supporting the organisation through ongoing and significant growth and investment.

  December 6, 2017

   · 

  1 min read
• Business

  AMRA and Artialis Join Forces in Sarcopenia Clinical Studies

  The results of the collaboration will be analyzed with the aim of identifying new, more specific biomarkers for sarcopenia.

  December 6, 2017

   · 

  3 min read
• BioMidwest

  New Promega Maxwell RSC PureFood Pathogen Kit Offers Food Labs Quick, Consistent Automated DNA Purification

  The kit does not require enzymatic pre-treatment and, when used in combination with the Maxwell RSC Instrument, can effectively purify DNA from 1 to 16 food matrix samples in 40 minutes, saving time for those who need to make quick decisions about potential food spoilage and contamination.

  December 6, 2017

   · 

  3 min read
• BioCapital

  AstraZeneca to Highlight its Commitment to Blood Cancers at the 2017 ASH Annual Meeting

  Presentations will include new data from AstraZeneca’s emerging hematology portfolio in several cancer types including mantle cell lymphoma.

  December 6, 2017

   · 

  11 min read
• Ipsen Announces Its Corporate Agenda for 2018

  Ipsen is a global specialty-driven biopharmaceutical group focused on innovation and specialty care.

  December 6, 2017

   · 

  2 min read
• GW Pharmaceuticals Announces Proposed Public Offering of ADSs - Dec. 6, 2017

  The price for the offering has not yet been determined.

  December 6, 2017

   · 

  6 min read
• Biotech Bay

  Evolve BioSystems’ Activated B. infantis EVC001 Demonstrates Substantial and Persistent Remodeling of the Infant Gut Microbiome

  The study showed that providing dietary B. infantis EVC001 resulted in rapid, substantial, and persistent remodeling of the gut microbiome in breastfed infants.

  December 6, 2017

   · 

  5 min read
• Tetra Bio-Pharma Opens Markets at TSX Listing Ceremony

  The listing ceremony took place at the TMX Broadcast Centre in Toronto, Ontario. Bernard Fortier, Chief Executive Officer (CEO), and Bernard Lessard, Chief Financial Officer, represented Tetra at the listing ceremony.

  December 6, 2017

   · 

  5 min read